<bill session="108" type="h" number="2700" updated="2013-07-14T19:01:43-04:00">
  <state datetime="2003-07-10">REFERRED</state>
  <status>
    <introduced datetime="2003-07-10"/>
  </status>
  <introduced datetime="2003-07-10"/>
  <titles>
    <title as="introduced" type="short">Medicare Patient Access to Drugs for Rare Diseases Act of 2003</title>
    <title as="introduced" type="official">To amend title XVIII of the Social Security Act to revise the methodology by which payment for orphan drugs and biologicals is made under program prospective payment system for hospital outpatient department services under the Medicare Program.</title>
  </titles>
  <sponsor id="400083"/>
  <cosponsors>
    <cosponsor id="400002" joined="2003-10-01"/>
    <cosponsor id="400007" joined="2003-10-10"/>
    <cosponsor id="400018" joined="2003-09-03"/>
    <cosponsor id="400025" joined="2003-07-10"/>
    <cosponsor id="400039" joined="2003-07-24"/>
    <cosponsor id="400043" joined="2003-07-10"/>
    <cosponsor id="400057" joined="2003-09-23"/>
    <cosponsor id="400073" joined="2003-07-24"/>
    <cosponsor id="400115" joined="2003-09-23"/>
    <cosponsor id="400120" joined="2003-10-17"/>
    <cosponsor id="400122" joined="2003-07-10"/>
    <cosponsor id="400124" joined="2003-09-23"/>
    <cosponsor id="400140" joined="2003-11-04"/>
    <cosponsor id="400162" joined="2003-11-18"/>
    <cosponsor id="400181" joined="2003-09-24"/>
    <cosponsor id="400196" joined="2003-07-10"/>
    <cosponsor id="400218" joined="2003-11-04"/>
    <cosponsor id="400231" joined="2003-07-24"/>
    <cosponsor id="400249" joined="2003-10-17"/>
    <cosponsor id="400262" joined="2003-07-15"/>
    <cosponsor id="400275" joined="2004-04-21"/>
    <cosponsor id="400290" joined="2003-09-03"/>
    <cosponsor id="400296" joined="2003-07-10"/>
    <cosponsor id="400308" joined="2003-09-23"/>
    <cosponsor id="400323" joined="2003-07-10"/>
    <cosponsor id="400326" joined="2003-10-10"/>
    <cosponsor id="400342" joined="2003-09-03"/>
    <cosponsor id="400343" joined="2003-09-03"/>
    <cosponsor id="400350" joined="2003-07-16"/>
    <cosponsor id="400355" joined="2004-02-24"/>
    <cosponsor id="400356" joined="2003-09-23"/>
    <cosponsor id="400373" joined="2003-07-16"/>
    <cosponsor id="400400" joined="2003-11-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-07-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-07-10">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-07-10">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2003-07-22">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2003-07-23">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Ambulatory care"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cost accounting"/>
    <term name="Drugs"/>
    <term name="Governmental investigations"/>
    <term name="Hemophilia"/>
    <term name="Hospital rates"/>
    <term name="Medicare"/>
    <term name="Orphan drugs"/>
    <term name="Overhead costs"/>
    <term name="Pharmacies"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>7/10/2003--Introduced.
Medicare Patient Access to Drugs for Rare Diseases Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act to revise the methodology by which payment for orphan drugs and biologicals is made under the Medicare prospective payment system for hospital outpatient department (OPD) services. Directs the Secretary to report to specified congressional committees on payment for orphan drugs and biologicals and blood clotting factors for individuals with hemophilia in the OPD setting, including recommendations for either continuing or discontinuing the exclusion of such drugs and biologicals from payment under Medicare. Provides for a moratorium on decreases in payment rates for orphan drugs and biologicals and blood clotting factors for certain individuals with hemophilia.</summary>
</bill>
